December 2018

Abstract

American Society of Hematology Annual Meeting

Flatiron-authored

December 2018

Abstract

American Society of Hematology Annual Meeting

Flatiron-authored

December 2018

Abstract

American Society of Hematology Annual Meeting

Flatiron-authored

December 2018

Abstract

American Society of Hematology Annual Meeting

December 2018

Abstract

American Society of Hematology Annual Meeting

Treatment Patterns Among Adults with Newly Diagnosed Primary Immune Thrombocytopenia in the United States

Cetin K, McGrath L, Overman R, Reams D, Sharma A, Brookhart MA, Altomare I, Wasser JS

December 2018

Abstract

American Society of Hematology Annual Meeting

December 2018

Abstract

American Society of Hematology Annual Meeting

December 2018

Abstract

American Society of Hematology Annual Meeting

Comparative Efficacy Of Nivolumab±ipilimumab Versus Standard of Care (SOC) For Third-Line (3L) Patients with Recurrent Small Cell Lung Cancer (SCLC) Using Population-Adjusted Indirect Comparison

Cope S, Popoff E, Keeping S, Goldgrub R, Jansen JP, Penrod J, Abraham P, Camidge DR, Korytowsky B, Gu T, Schoenherr N, Juarez-Garcia A, Le T, Yuan Y

November 2018

Abstract

EU ISPOR

October 2018

Abstract

Society of Melanoma Research

October 2018

Abstract

Society of Melanoma Research

October 2018

Abstract

Society of Melanoma Research

October 2018

Abstract

ESMO Annual Congress

October 2018

Abstract

ESMO Annual Congress

Flatiron-authored

October 2018

Abstract

ESMO Annual Congress

October 2018

Abstract

ESMO Annual Congress

October 2018

Abstract

ESMO Annual Congress

October 2018

Abstract

ESMO Annual Congress

October 2018

Abstract

ESMO Annual Congress

October 2018

Abstract

ESMO Annual Congress

October 2018

Abstract

ESMO Annual Congress

October 2018

Abstract

ESMO Annual Congress

October 2018

Abstract

ESMO Annual Congress

Distinctive Clinical Characteristics of SCLC in Never-Smokers

Mian I, Nichols S, Abernethy AP, Carson K, Maignan K, Torres AZ, Snider J, Frampton G, Li G, Sharon E, Szabo E, Thomas A

September 2018

Abstract

World Conference on Lung Cancer

Flatiron-authored

Sequencing of Ramucirumab+Docetaxel Postimmune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer

Clarke JM, Stefaniak VJ, Batus M, Winfree KB, Molife C, Cui Z, Han Y, Tawney MK, Bonomi PD

September 2018

Abstract

World Conference on Lung Cancer

Prognosis of Non-Driver, Never Smoker Metastatic Non-Small Lung Cancer (NSCLC)

Chalmers AW, Haaland B, Patel SB, Moynahan K, Cannon L, Akerley W

September 2018

Abstract

World Conference on Lung Cancer

Ramucirumab+Docetaxel Usage Following Rapid Disease Progression in Real World Advanced Non-Small Cell Lung Cancer Patients

Batus M, Molife C, Clarke JM, Stefaniak VJ, Winfree KB, Cui Z, Han Y, Tawney MK, Bonomi PD

September 2018

Abstract

World Conference on Lung Cancer

September 2018

Abstract

World Conference on Lung Cancer

Treatment Patterns and Overall Survival Following Biomarker Testing in Real-World Advanced NSCLC Patients

Barlesi F, Paz-Ares L, Page D, Shewade A, Lambert P, Mughal T, Gay L, Khorshid M, Arnieri B, Capra W, Foser S, Mascaux C, Bubendorf L, Wang L

September 2018

Abstract

World Conference on Lung Cancer

Real World Biomarker Testing and Treatment Patterns in Patients with Advanced NSCLC Receiving EGFR TKIs

Chiang A, Fernandes A, Pavilack M, Wu J, Laliberté F, Duh MS, Chehab N, Subramanian J

September 2018

Abstract

World Conference on Lung Cancer

The Impact of Missing Deaths on Survival Analyses Conducted in an Oncology EHR Database

Carrigan G, Whipple S, Taylor M, Torres AZ, Gossai A, Arnieri B, Tucker M, Hofmeister PP, Lambert P, Griffith S, Capra W

August 2018

Abstract

International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE)

Flatiron-authored

Proof-of-Concept for using External Control Arms Derived from Electronic Health Records (EHR) to Replace Control Arms from Randomized Controlled Trials (RCT)

Carrigan G, Whipple S, Capra W, Taylor M, Lu M, Arnieri B, Brown JS, Abernethy AP, Copping R, Rothman KJ

August 2018

Abstract

International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE)

Flatiron-authored

August 2018

Abstract

International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE)

August 2018

Abstract

International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE)

August 2018

Abstract

International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE)

Development and Validation of a High-Quality Composite Real-World Mortality Endpoint

Curtis MD, Griffith S, Tucker M, Taylor M, Capra W, Carrigan G, Holzman B, Torres AZ, You P, Arnieri B, Abernethy AP

June 2018

Abstract

Academy Health Annual Research Meeting

Flatiron-authored

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

June 2018

Abstract

ASCO Annual Meeting

June 2018

Abstract

ASCO Annual Meeting

Real-world Data (RWD) on Tumor Response (rwTR) in Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients Receiving Cancer Immunotherapy and Targeted Therapies

Lu M, Sadetsky N, Lambert P, Whipple S, Taylor M, Riehl T, Riely GJ

June 2018

Abstract

ASCO Annual Meeting

Risk Stratification Using Patient-Reported Outcomes (PROs) in Patients (pts) with Advanced Cancer

Patel SB, Haaland B, Ose D, Haydell T, Martineau J, Dunson W, Chalmers AW, Cannon L, Kissell B, Meropol N, Akerley W

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

Development of a Dashboard for End-of-Life Care at an Academic Hospital

Adelson K, Meropol N, Hamrick HJ, Haydell T, Martineau J, Kraut J, Severino KM, Lilenbaum R

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

Age-Related Real-World Outcomes for Patients (pts) with Metastatic Colorectal Cancer (mCRC)

Curtis MD, Nussbaum N, Hamrick HJ, Bennette CS, Meropol N, Miksad RA

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

June 2018

Abstract

ASCO Annual Meeting

June 2018

Abstract

ASCO Annual Meeting

June 2018

Abstract

ASCO Annual Meeting

June 2018

Abstract

ASCO Annual Meeting

June 2018

Abstract

ASCO Annual Meeting

June 2018

Abstract

ASCO Annual Meeting

June 2018

Abstract

ASCO Annual Meeting

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

Real World Outcomes of Metastatic Pancreatic Cancer (mPC) Patients (pts) Treated with Liposomal Irinotecan (nal-IRI) in the US

Barzi A, Miksad RA, Surinach A, Corvino F, Wang S, Torres AZ, Mamlouk KK, Pulgar SJ, Bekaii-Saab TS

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

Sequencing of Ramucirumab (ram) and Immune Checkpoint Inhibitors (ICIs) in Platinum (Pt)-Treated Real-World Patients (pts) with Advanced Non-Small Cell Lung Cancer (aNSCLC)

Clarke JM, Molife C, Miksad RA, Batus M, Winfree KB, Gossai A, Stefaniak VJ, Foster R, Cui Z, Torres AZ, Feuchtbaum D, Tawney MK, Bonomi PD

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

Identifying the Prognostic Significance of Genomic Alterations in a Real-World, EHR-Derived Clinico-Genomic Database (CGDB)

Agarwala V, Backenroth D, Singal G, O'Connell C, Li G, Alpha-Cobb G, Kaushik G, Carson K, Miller V, Abernethy AP

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

Prevalence of Microsatellite Instability and Association with Pembrolizumab (P) Usage in a Real-World Clinico-Genomic Database

O'Connell C, Backenroth D, Singal G, Agarwala V, Li G, Kaushik G, Alpha-Cobb G, Kao CK, Miller V, Abernethy AP, Carson K

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

ICD-Coded Information on Sites of Metastasis in Oncology Real-World Data is Specific But Not Sensitive

Parrinello CM, Seidl-Rathkopf K, Bennette CS, Bourla A, Nussbaum N, Carson K, Abernethy AP

May 2018

Abstract

ISPOR Annual Meeting

Flatiron-authored

May 2018

Abstract

ISPOR Annual Meeting

Flatiron-authored

May 2018

Abstract

Academy Health Annual Research Meeting

Flatiron-authored

Identification of Resistance Mechanisms to EGFR Treatment in the Real World Using a Clinicogenomic Database

Singal G, Agarwal A, Kaushik G, O'Connell C, Alpha-Cobb G, Caron T, Bourque D, Guria A, Frank S, Frampton G, Carson K, Abernethy AP, Miller V

April 2018

Abstract

American Association for Cancer Research Annual Meeting

Flatiron-authored

Use of Cancer Immunotherapies in the Real-World in the Setting of Microsatellite Instability

Agarwala V, Gossai A, Singal G, O'Connell C, Li G, Kao K, Bourque D, Feuchtbaum D, Nunnally A, Frampton G, Ali S, Abernethy AP, Kramarz S, Trabucco SE

January 2018

Abstract

ASCO-SITC Clinical Immuno-Oncology Symposium

Flatiron-authored

January 2018

Abstract

ASCO-SITC Clinical Immuno-Oncology Symposium

January 2018

Abstract

ASCO-SITC Clinical Immuno-Oncology Symposium

January 2018

Abstract

ASCO Gastrointestinal Cancers Symposium

December 2017

Abstract

American Society of Hematology Annual Meeting

December 2017

Abstract

American Society of Hematology Annual Meeting

December 2017

Abstract

American Society of Hematology Annual Meeting

December 2017

Abstract

American Society of Hematology Annual Meeting

December 2017

Abstract

American Society of Hematology Annual Meeting

December 2017

Abstract

American Society of Hematology Oncology

December 2017

Abstract

San Antonio Breast Cancer Symposium

Treatment Patterns for Young Women with HR+/HER2- Metastatic Breast Cancer in the United States in the Era of CDK 4/6 Inhibitors

Burstein H, Mayer E, DeMichele A, Harnett J, Mardekian J, McRoy L, Huang Bartlett C, Koehler M, Fahed Rimawi M

December 2017

Abstract

San Antonio Breast Cancer Symposium

November 2017

Abstract

San Antonio Breast Cancer Symposium

Flatiron-authored

October 2017

Abstract

World Conference on Lung Cancer

Utilization and Timing of Foundation Medicine (FMI) Testing in U.S. Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients

Wang L, Page D, Shewade A, Lambert P, Arnieri B, Capra W, Khorshid M, Mughal T, Gay L, Foser S

October 2017

Abstract

World Conference on Lung Cancer

October 2017

Abstract

World Conference on Lung Cancer

October 2017

Abstract

World Conference on Lung Cancer

Real-World Management of Patients with EGFR Mutation-Positive NSCLC in the US

Li Y, Appius A, Pattipaka T, Feyereislova A, Cassidy A, Ganti A

October 2017

Abstract

World Conference on Lung Cancer

October 2017

Abstract

World Conference on Lung Cancer

Immune Checkpoint Inhibitor (ICPI) Efficacy and Resistance Detected by Comprehensive Genomic Profiling (CGP) in Non-Small Cell Lung Cancer (NSCLC)

Ross J, Goldberg M, Albacker L, Gay L, Agarwala V, Elvin J, Vergillo J, Ramkissoon S, Severson E, Daniel S, Ali S, Schrock A, Frampton G, Fabrizio D, Miller V, Singal G, Abernethy AP, Stephens P

September 2017

Abstract

ESMO Annual Congress

Flatiron-authored

Analyzing Biomarkers of Cancer Immunotherapy (CIT) Response Using a Real-World Clinico-Genomic Database

Singal G, Miller P, Agarwala V, Li G, Gossai A, Albacker L, Goldberg M, He J, Frank S, Bourque D, Ivanov V, Fabrizio D, Caron T, Parker A, Guria A, Miller V, Elvin J, Ross J, Abernethy AP, Stephens P

September 2017

Abstract

ESMO Annual Congress

Flatiron-authored

September 2017

Abstract

ESMO Annual Congress

September 2017

Abstract

ESMO Annual Congress

June 2017

Abstract

ASCO Annual Meeting

Flatiron-authored

Implementation of the IOM 13 Point Care Plan by OCM Practices

Fargnoli B, Jaffe N, Bauer-Levey N, Cowing K, Schneider J, Parulkar R, Lee D, Harary O, Holleran R, Zhang S, Revol C, Tran D, Shah R, Abernethy AP, Kolodziej M

June 2017

Abstract

ASCO Annual Meeting

Flatiron-authored

Electronic Calculation of Quality Measures in the EMR is Highly Dependent on Data Capture in Structured Fields: The Oncology Care Model (OCM) Quality Reporting Experience

Hamrick HJ, Revol C, Parulkar R, Lemmers O, Gippetti J, Bauer-Levey N, Lee D, Fugaro A, Kolodziej M, Green R, Abernethy AP

June 2017

Abstract

ASCO Annual Meeting

Flatiron-authored

June 2017

Abstract

ASCO Annual Meeting

Flatiron-authored

Adoption of Immunotherapy into Real World Practice: Insights from the Use of Checkpoint Inhibitors

O’Connor J, Seidl-Rathkopf K, You P, Nussbaum N, Torres AZ, Fessele K, Darius K, Adelson K, Yin E, Presley C, Chiang A, Ross J, Abernethy AP, Gross C

June 2017

Abstract

ASCO Annual Meeting

Flatiron-authored

Racial Disparities in the Use of Programmed Death-1 Checkpoint Inhibitors

O’Connor J, Seidl-Rathkopf K, You P, Nussbaum N, Torres AZ, Fessele K, Darius K, Adelson K, Yin E, Presley C, Chiang A, Ross J, Abernethy AP, Gross C

June 2017

Abstract

ASCO Annual Meeting

Flatiron-authored

Disparities in Next Generation Sequencing in a Population-Based Community Cohort of Patients with Advanced Non-Small Cell Lung Cancer

Presley C, Chiang A, Longtine J, Soulos P, Adelson K, Herbst R, Nussbaum N, Sorg R, Abernethy AP

June 2017

Abstract

ASCO Annual Meeting

Flatiron-authored

Development and Validation of a Real-World Clinico-Genomic Database

Singal G, Miller P, Agarwala V, He J, Gossai A, Frank S, Bourque D, Bowser B, Caron T, Baydur E, Seidl-Rathkopf K, Ivanov I, Parker A, Guria A, Frampton G, Jaskiw A, Feuchtbaum D, Nussbaum N, Abernethy AP, Miller V

June 2017

Abstract

ASCO Annual Meeting

Flatiron-authored

June 2017

Abstract

ASCO Annual Meeting

June 2017

Abstract

ASCO Annual Meeting

Characteristics of Advanced NSCLC Patients Receiving Molecular Diagnostic Testing in US Routine Clinical Practice

Wang L, Shewade A, Lambert P, Arnieri B, Capra W, Khroshid M, Mughal T, Gay L, Page D, Foser S

June 2017

Abstract

ASCO Annual Meeting

June 2017

Abstract

ASCO Annual Meeting

Real-World Treatment Pattern and Discontinuation of Systemic Combination Therapies in Metastatic Melanoma

Qiu Y, Li Z, Tang J, Atanasov P, Mahmood S, Grzegorzewski K, Chen L, Chen J

June 2017

Abstract

ASCO Annual Meeting

May 2017

Abstract

European Lung Cancer Conference

Real-World Rates of Chemotherapy Use Near the End of Life (EOL) in Cancer Patients

Agarwala V, Kraut J, Gippetti J, Revol C, Peterson D, Fessele K, Abernethy AP

March 2017

Abstract

NCCN Annual Conference

Flatiron-authored

The NCCN-Flatiron Outcomes Database: Collaborative Evidence Development and Quality Improvement in Oncology

Agarwala V, Birnbaum B, Gippetti J, Talcott L, Kraut J, Bowser B, Delgado J, Nightingale C, Lvov M, Nussbaum N, Connolly D, Martineau J, Darius K, Fessele K, McClure J, Fitzgerald L, Carlson R, Abernethy AP

March 2017

Abstract

NCCN Annual Conference

Flatiron-authored

Total Cost of Care in Patients with Advanced Non-Small Cell Lung Cancer Receiving Oral Targeted Therapy vs. Standard Therapy

Gabriel PE, Berman AT, Guttman D, Stetson R, Kruse G, Morrissette J, Agarwala V, Kraut J, Abernethy AP, Shulman LN, Evans T

March 2017

Abstract

Personalized Medicine Conference-Fusion

Flatiron-authored

Chemotherapy Use Near End of Life (EOL): Measuring Real World Benchmarks

Kraut J, Gippetti J, Peterson D, Agarwala V, Revol C, Fessele K, Abernethy AP

March 2017

Abstract

ASCO Quality Care Symposium

Flatiron-authored

March 2017

Abstract

ASCO Quality Care Symposium

Flatiron-authored

March 2017

Abstract

ASCO Quality Care Symposium

Validation of Diagnosis Codes to Identify Side of Colon in an Electronic Health Record Registry

Luhn P, Kuk D, Carrigan G, Nussbaum N, Sorg R, Rohrer R, Tucker M, Arnieri B, Taylor M, Abernethy AP

January 2017

Abstract

ASCO Gastrointestinal Cancers Symposium

Flatiron-authored

January 2017

Abstract

ASCO Gastrointestinal Cancers Symposium

December 2016

Abstract

European Society for Medical Oncology ASIA

December 2016

Abstract

American Society of Hematology Annual Meeting

December 2016

Abstract

American Society of Hematology Oncology

October 2016

Abstract

EU ISPOR

Initiation and Adherence with Bone-Targeting Agents in US Men with Bone Metastases from Prostate Cancer

Butler A, Ceitin K, Hernandez RK, Overman R, Kim J, Reams D, Hirsch B, Abernethy AP, Liede A, Brookhart A

August 2016

Abstract

International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE)

Flatiron-authored

Initiation and Adherence with Bone-Targeting Agents in US Men with Bone Metastases from Prostate Cancer

Butler A, Ceitin K, Hernandez RK, Overman R, Kim J, Reams D, Hirsch B, Abernethy AP, Liede A, Brookhart A

June 2016

Abstract

Meeting of the Canadian Urological Association

Flatiron-authored

June 2016

Abstract

ASCO Annual Meeting

Flatiron-authored

Initiation and Adherence with Bone-Targeting Agents in US Men with Bone Metastases from Prostate Cancer

Butler A, Ceitin K, Hernandez RK, Overman R, Kim J, Reams D, Hirsch B, Abernethy AP, Liede A, Brookhart A

June 2016

Abstract

ASCO Annual Meeting

Flatiron-authored

January 2016

Abstract

ASCO Gastrointestinal Cancers Symposium

January 2016

Abstract

ASCO Gastrointestinal Cancers Symposium

September 2015

Abstract

European Cancer Congress

Flatiron-authored

Real-World Bortezomib Usage Patterns Among Patients with Relapsed/Refractory Multiple Myeloma

Calkins G, Kohansimeh J, Krishna A, Green R, Curtis MD, Lindberg F, Jaskiw A, Larrabee K, Terry M, Feinstein RN, Plotkin L, Palladino ML, Nicacio L

June 2015

Abstract

EHA Learning Center

Flatiron-authored

BRAF, KIT, and NRAS Testing Patterns and Results in Metastatic Melanoma

Abernethy AP, Fung C, Richardson P, Eisenberg D, Connolly D, Terry M, Feinstein RN, Tucker M, Miller C, Nicacio L

June 2015

Abstract

ASCO Annual Meeting

Flatiron-authored